In present study, we found Icaritin, a compound purified from traditional herb medicine exhibited a potent anti-leukemia activities towards established CML cell line-K562 and primary bone marrow cells (including CD34+ cells) from CML patients. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.